Stock screener

TECH

Conviction 73HealthcareScan · Tue, Sep 8, 2026
TECH$72.31-0.17%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Vol MA14 2.31M
Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8
BIO-TECHNE CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.bio-techne.com
Price72.31
Change-0.17%
Gap-0.10%
Rel volume1.06×
Avg volume2.37M
Avg $ vol171.49M
SMA 2072.33
SMA 5071.87
SMA 20061.07
Price vs 50+0.61%
Price vs 200+18.40%
MA stackbullish
50/200 cross
Supertrendup · 71.77
RSI (14)61
MACD hist-0.18
MACD cross
Stoch %K / %D39 / 56
ADX (14)52
+DI / −DI27 / 13
RSI divergence
MACD divergence
ATR %+0.40%
ADR %0.29%
52w high72.48
52w low43.30
From 52w high-0.23%
Above 52w low+67.00%
New 52w highYes
SqueezeOn · 21d
Bollinger width0.54%
%B0.46
Donchian pos50.00%
Donchian high72.62
Donchian low72.00
AVWAP (52w high)72.36
vs AVWAP high-0.07%
AVWAP (52w low)66.71
vs AVWAP low+8.40%
OBV trendFlat
Chaikin MF (20)-0.14
Today vs 20d1.06×
Avg vol (14d)2.31M
Avg vol (20d)2.37M
Avg $ vol (20d)171.49M
Market cap11.34B
RS 3m (vs SPY)+34.89%
RS 6m (vs SPY)+19.86%
RS line new highNo
Trend template6/8
Technical rank76.3
1 week+0.00%
1 month+0.03%
3 months+37.34%
6 months+31.78%
1 year+32.90%
YTD+21.22%
P/E154.49
P/B5.38
P/S9.33
P/FCF43.08
EPS1.16
Div yield0.44%
ROE3.48%
ROA2.84%
Debt/Eq0.01
Current4.55
EV/EBITDA31.75
Gross margin65.77%
Net margin6.04%
Rev growth-0.38%
EPS growth-56.34%
Price target72.11
Target upside-0.28%
Analyst ratingHold
Institutional125.10%
Ent. value11.09B
Revenue311.42M
Net income51.05M
Gross profit208.29M
Free cash flow263.22M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out156.57M
Employees3.1K
ListedMon, May 8, 1989
Free float154.83M
Float %99.0%
Short interest6.46M
Days to cover2.3d
Short volume41.8%
Squeeze score22 / 100
Next earnings
EPS forecast
Last EPS vs est$0.49 vs $0.46
Last surprise+6.5% beat
Setup gradeB
Conviction73 / 100
Pattern quality
Tech rank76.3 / 100
Group rank96 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance72.57
Support71.64
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TECH · 9 recent

All disclosures →
MemberSideAmount
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2026-01-28
Sell$1K–$15K
April McClain Delaney
April McClain Delaney
house · MD · traded 2025-12-05
Buy$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-08-01
Sell$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-05-26
Sell$1K–$15K
Julie Johnson
Julie Johnson
house · D · TX · traded 2025-04-01
Sell$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-04-08
Sell$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-04-09
Buy$1K–$15K
April McClain Delaney
April McClain Delaney
house · D · MD · traded 2025-04-29
Buy$1K–$15K
Rob Bresnahan
Rob Bresnahan
house · PA · traded 2025-02-25
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in TECH · 10 buys

InsiderSideShares
Crouse Steven C.
President - Diag & Spatial Bi · Restricted Stock Units · 2026-08-17
Grant8.7K
Crouse Steven C.
President - Diag & Spatial Bi · Restricted Stock Units · 2026-08-17
Grant14.14K
Geist William
PRESIDENT, PROTEIN SCIENCES · Restricted Stock Units · 2026-08-17
Grant14.76K
Geist William
PRESIDENT, PROTEIN SCIENCES · Restricted Stock Units · 2026-08-17
Grant23.98K
Herr Amy E.
Director · Restricted Stock Units · 2026-08-17
Grant1.38K
Hippel James
CFO · Restricted Stock Units · 2026-08-17
Grant22.44K
Hippel James
CFO · Restricted Stock Units · 2026-08-17
Grant36.46K
Kelderman Kim
Chief Executive Officer · Restricted Stock Units · 2026-08-17
Grant57.59K
Kelderman Kim
Chief Executive Officer · Restricted Stock Units · 2026-08-17
Grant93.58K
Bohnen Shane
SVP - General Counsel · Restricted Stock Units · 2026-08-17
Grant11.34K

SEC filings

EDGAR filings in TECH · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.